Surov Alexey, Pech Maciej, Omari Jazan, Fischbach Frank, Damm Robert, Fischbach Katharina, Powerski Maciej, Relja Borna, Wienke Andreas
Department of Radiology and Nuclear Medicine University of Magdeburg, Magdeburg, Germany.
Institute of Medical Epidemiology, Biostatistics, and Informatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Liver Cancer. 2021 Feb;10(1):10-24. doi: 10.1159/000511384. Epub 2021 Jan 27.
To date, there are inconsistent data about relationships between diffusion-weighted imaging (DWI) and tumor grading/microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Our purpose was to systematize the reported results regarding the role of DWI in prediction of tumor grading/MVI in HCC.
MEDLINE library, Scopus, and Embase data bases were screened up to December 2019. Overall, 29 studies with 2,715 tumors were included into the analysis. There were 20 studies regarding DWI and tumor grading, 8 studies about DWI and MVI, and 1 study investigated DWI, tumor grading, and MVI in HCC.
In 21 studies (1,799 tumors), mean apparent diffusion coefficient (ADC) values (ADC) were used for distinguishing HCCs. ADC of G1-3 lesions overlapped significantly. In 4 studies (461 lesions), minimum ADC (ADC) was used. ADC values in G1/2 lesions were over 0.80 × 10 mm/s and in G3 tumors below 0.80 × 10 mm/s. In 4 studies (241 tumors), true diffusion () was reported. A significant overlapping of values between G1, G2, and G3 groups was found. ADC and MVI were analyzed in 9 studies (1,059 HCCs). ADC values of MIV+/MVI- lesions overlapped significantly. ADC was used in 4 studies (672 lesions). ADC values of MVI+ tumors were in the area under 1.00 × 10 mm/s. In 3 studies (227 tumors), was used. Also, values of MVI+ lesions were predominantly in the area under 1.00 × 10 mm/s.
ADC reflects tumor grading, and ADC and predict MVI in HCC. Therefore, these DWI parameters should be estimated for every HCC lesion for pretreatment tumor stratification. ADC cannot predict tumor grading/MVI in HCC.
迄今为止,关于肝细胞癌(HCC)中扩散加权成像(DWI)与肿瘤分级/微血管侵犯(MVI)之间的关系,数据存在不一致性。我们的目的是系统整理已报道的关于DWI在预测HCC肿瘤分级/MVI中的作用的结果。
检索MEDLINE数据库、Scopus和Embase数据库直至2019年12月。总共29项研究共2715个肿瘤纳入分析。其中20项研究涉及DWI与肿瘤分级,8项研究关于DWI与MVI,1项研究调查了HCC中的DWI、肿瘤分级和MVI。
在21项研究(1799个肿瘤)中,平均表观扩散系数(ADC)值用于区分HCC。G1 - 3级病变的ADC值有显著重叠。在4项研究(461个病灶)中,使用最小ADC(ADC)。G1/2级病变的ADC值超过0.80×10⁻³mm²/s,G3级肿瘤低于0.80×10⁻³mm²/s。在4项研究(241个肿瘤)中,报道了真实扩散率(D)。发现G1、G2和G3组之间的D值有显著重叠。在9项研究(1059个HCC)中分析了ADC与MVI。MIV+/MVI-病变的ADC值有显著重叠。4项研究(672个病灶)中使用ADC。MVI+肿瘤的ADC值在1.00×10⁻³mm²/s以下区域。3项研究(227个肿瘤)中使用D。同样,MVI+病变的D值主要在1.00×10⁻³mm²/s以下区域。
ADC反映肿瘤分级,ADC和D可预测HCC中的MVI。因此,应为每个HCC病变评估这些DWI参数以进行治疗前肿瘤分层。ADC无法预测HCC中的肿瘤分级/MVI。